SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset
27 Oct, 2020 | 09:44h | UTC
Commentary on Twitter
Neutralizing antibodies to SARS-CoV-2 Spike RBD, 40-199 days after symptom end:
– ~90% of patients have
– ~75% of them (~68%) have high titre (>300)
– no age difference
– higher in hospital cases and males
– lower with steroidsShould last a few years.https://t.co/OYZV6gRfyA https://t.co/Zdhj3W7yGw pic.twitter.com/eTUF870q05
— ice9 (@__ice9) October 24, 2020